Early last week we sold Pfizer across all accounts invested in our dividend growth strategy.* We initially invested in Pfizer because it was undervalued, had an above average dividend yield, was growing its dividend, and it looked like the company… Read More
This is from the AMM Dividend Letter released April 7, 2016. If you want to see the latest “Dividend Stock in Focus” as soon as it’s released then join our mailing list here. This is the competition. It’s you versus… Read More
We’re always big fans of confirmation bias. Today’s confirmation bias comes from Barron’s. They ran a screen for companies with dividend yields greater than the S&P 500’s current yield and with increasing earnings estimates. Barron’s came up with 4 and… Read More
For those of you who have been paying into Social Security for your entire working careers, the day when you finally retire and begin